Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction

類似資料

• Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia
  著者:: Nersting, Jacob, 等
  出版事項: (2011)
• Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
  著者:: Schmiegelow, Kjeld, 等
  出版事項: (2009)
• Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
  著者:: Mogensen, Pernille Rudebeck, 等
  出版事項: (2020)
• Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
  著者:: Wojtuszkiewicz, Anna, 等
  出版事項: (2015)
• Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
  著者:: Levinsen, Mette, 等
  出版事項: (2014)